 | • レポートコード：MRC2-11QY10767 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はトゥレット症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（AZD-5213、CPP-115、Dutetrabenazine ER、Ecopipam Hydrochloride、Others）市場規模、用途別（研究センター、病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別トゥレット症候群治療薬の競争状況、市場シェア ・世界のトゥレット症候群治療薬市場：種類別市場規模 2015年-2020年（AZD-5213、CPP-115、Dutetrabenazine ER、Ecopipam Hydrochloride、Others） ・世界のトゥレット症候群治療薬市場：種類別市場規模予測 2021年-2026年（AZD-5213、CPP-115、Dutetrabenazine ER、Ecopipam Hydrochloride、Others） ・世界のトゥレット症候群治療薬市場：用途別市場規模 2015年-2020年（研究センター、病院、診療所、その他） ・世界のトゥレット症候群治療薬市場：用途別市場規模予測 2021年-2026年（研究センター、病院、診療所、その他） ・北米のトゥレット症候群治療薬市場分析：米国、カナダ ・ヨーロッパのトゥレット症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのトゥレット症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のトゥレット症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのトゥレット症候群治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abide Therapeutics Inc、Catalyst Pharmaceuticals Inc、Neurocrine Biosciences Inc、Psyadon Pharmaceuticals Inc、Reviva Pharmaceuticals Inc、Synchroneuron Inc、Teva Pharmaceutical Industries Ltd、Therapix Biosciences Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Tourette Syndrome Drug Market
The global Tourette Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tourette Syndrome Drug Scope and Market Size
Tourette Syndrome Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tourette Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tourette Syndrome Drug market is segmented into
AZD-5213
CPP-115
Dutetrabenazine ER
Ecopipam Hydrochloride
Others
Segment by Application, the Tourette Syndrome Drug market is segmented into
Research Center
Hospital
Clinic
Others
Regional and Country-level Analysis
The Tourette Syndrome Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tourette Syndrome Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tourette Syndrome Drug Market Share Analysis
Tourette Syndrome Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tourette Syndrome Drug business, the date to enter into the Tourette Syndrome Drug market, Tourette Syndrome Drug product introduction, recent developments, etc.
The major vendors covered:
Abide Therapeutics Inc
Catalyst Pharmaceuticals Inc
Neurocrine Biosciences Inc
Psyadon Pharmaceuticals Inc
Reviva Pharmaceuticals Inc
Synchroneuron Inc
Teva Pharmaceutical Industries Ltd
Therapix Biosciences Ltd
1 Study Coverage
1.1 Tourette Syndrome Drug Product Introduction
1.2 Market Segments
1.3 Key Tourette Syndrome Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tourette Syndrome Drug Market Size Growth Rate by Type
1.4.2 AZD-5213
1.4.3 CPP-115
1.4.4 Dutetrabenazine ER
1.4.5 Ecopipam Hydrochloride
1.4.6 Others
1.5 Market by Application
1.5.1 Global Tourette Syndrome Drug Market Size Growth Rate by Application
1.5.2 Research Center
1.5.3 Hospital
1.5.4 Clinic
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tourette Syndrome Drug Market Size, Estimates and Forecasts
2.1.1 Global Tourette Syndrome Drug Revenue 2015-2026
2.1.2 Global Tourette Syndrome Drug Sales 2015-2026
2.2 Global Tourette Syndrome Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tourette Syndrome Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tourette Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tourette Syndrome Drug Competitor Landscape by Players
3.1 Tourette Syndrome Drug Sales by Manufacturers
3.1.1 Tourette Syndrome Drug Sales by Manufacturers (2015-2020)
3.1.2 Tourette Syndrome Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Tourette Syndrome Drug Revenue by Manufacturers
3.2.1 Tourette Syndrome Drug Revenue by Manufacturers (2015-2020)
3.2.2 Tourette Syndrome Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tourette Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Revenue in 2019
3.2.5 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tourette Syndrome Drug Price by Manufacturers
3.4 Tourette Syndrome Drug Manufacturing Base Distribution, Product Types
3.4.1 Tourette Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tourette Syndrome Drug Product Type
3.4.3 Date of International Manufacturers Enter into Tourette Syndrome Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tourette Syndrome Drug Market Size by Type (2015-2020)
4.1.1 Global Tourette Syndrome Drug Sales by Type (2015-2020)
4.1.2 Global Tourette Syndrome Drug Revenue by Type (2015-2020)
4.1.3 Tourette Syndrome Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tourette Syndrome Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Tourette Syndrome Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Tourette Syndrome Drug Revenue Forecast by Type (2021-2026)
4.2.3 Tourette Syndrome Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tourette Syndrome Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tourette Syndrome Drug Market Size by Application (2015-2020)
5.1.1 Global Tourette Syndrome Drug Sales by Application (2015-2020)
5.1.2 Global Tourette Syndrome Drug Revenue by Application (2015-2020)
5.1.3 Tourette Syndrome Drug Price by Application (2015-2020)
5.2 Tourette Syndrome Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Tourette Syndrome Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Tourette Syndrome Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Tourette Syndrome Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tourette Syndrome Drug by Country
6.1.1 North America Tourette Syndrome Drug Sales by Country
6.1.2 North America Tourette Syndrome Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tourette Syndrome Drug Market Facts & Figures by Type
6.3 North America Tourette Syndrome Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Tourette Syndrome Drug by Country
7.1.1 Europe Tourette Syndrome Drug Sales by Country
7.1.2 Europe Tourette Syndrome Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tourette Syndrome Drug Market Facts & Figures by Type
7.3 Europe Tourette Syndrome Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tourette Syndrome Drug by Region
8.1.1 Asia Pacific Tourette Syndrome Drug Sales by Region
8.1.2 Asia Pacific Tourette Syndrome Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Type
8.3 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tourette Syndrome Drug by Country
9.1.1 Latin America Tourette Syndrome Drug Sales by Country
9.1.2 Latin America Tourette Syndrome Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tourette Syndrome Drug Market Facts & Figures by Type
9.3 Central & South America Tourette Syndrome Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tourette Syndrome Drug by Country
10.1.1 Middle East and Africa Tourette Syndrome Drug Sales by Country
10.1.2 Middle East and Africa Tourette Syndrome Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Type
10.3 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Abide Therapeutics Inc
11.1.1 Abide Therapeutics Inc Corporation Information
11.1.2 Abide Therapeutics Inc Description and Business Overview
11.1.3 Abide Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
11.1.5 Abide Therapeutics Inc Related Developments
11.2 Catalyst Pharmaceuticals Inc
11.2.1 Catalyst Pharmaceuticals Inc Corporation Information
11.2.2 Catalyst Pharmaceuticals Inc Description and Business Overview
11.2.3 Catalyst Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
11.2.5 Catalyst Pharmaceuticals Inc Related Developments
11.3 Neurocrine Biosciences Inc
11.3.1 Neurocrine Biosciences Inc Corporation Information
11.3.2 Neurocrine Biosciences Inc Description and Business Overview
11.3.3 Neurocrine Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products Offered
11.3.5 Neurocrine Biosciences Inc Related Developments
11.4 Psyadon Pharmaceuticals Inc
11.4.1 Psyadon Pharmaceuticals Inc Corporation Information
11.4.2 Psyadon Pharmaceuticals Inc Description and Business Overview
11.4.3 Psyadon Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
11.4.5 Psyadon Pharmaceuticals Inc Related Developments
11.5 Reviva Pharmaceuticals Inc
11.5.1 Reviva Pharmaceuticals Inc Corporation Information
11.5.2 Reviva Pharmaceuticals Inc Description and Business Overview
11.5.3 Reviva Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
11.5.5 Reviva Pharmaceuticals Inc Related Developments
11.6 Synchroneuron Inc
11.6.1 Synchroneuron Inc Corporation Information
11.6.2 Synchroneuron Inc Description and Business Overview
11.6.3 Synchroneuron Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Synchroneuron Inc Tourette Syndrome Drug Products Offered
11.6.5 Synchroneuron Inc Related Developments
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products Offered
11.7.5 Teva Pharmaceutical Industries Ltd Related Developments
11.8 Therapix Biosciences Ltd
11.8.1 Therapix Biosciences Ltd Corporation Information
11.8.2 Therapix Biosciences Ltd Description and Business Overview
11.8.3 Therapix Biosciences Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products Offered
11.8.5 Therapix Biosciences Ltd Related Developments
11.1 Abide Therapeutics Inc
11.1.1 Abide Therapeutics Inc Corporation Information
11.1.2 Abide Therapeutics Inc Description and Business Overview
11.1.3 Abide Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
11.1.5 Abide Therapeutics Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tourette Syndrome Drug Market Estimates and Projections by Region
12.1.1 Global Tourette Syndrome Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Tourette Syndrome Drug Revenue Forecast by Regions 2021-2026
12.2 North America Tourette Syndrome Drug Market Size Forecast (2021-2026)
12.2.1 North America: Tourette Syndrome Drug Sales Forecast (2021-2026)
12.2.2 North America: Tourette Syndrome Drug Revenue Forecast (2021-2026)
12.2.3 North America: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Tourette Syndrome Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Tourette Syndrome Drug Sales Forecast (2021-2026)
12.3.2 Europe: Tourette Syndrome Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tourette Syndrome Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tourette Syndrome Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tourette Syndrome Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tourette Syndrome Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Tourette Syndrome Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Tourette Syndrome Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Tourette Syndrome Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tourette Syndrome Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tourette Syndrome Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tourette Syndrome Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tourette Syndrome Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tourette Syndrome Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tourette Syndrome Drug Market Segments
Table 2. Ranking of Global Top Tourette Syndrome Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tourette Syndrome Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AZD-5213
Table 5. Major Manufacturers of CPP-115
Table 6. Major Manufacturers of Dutetrabenazine ER
Table 7. Major Manufacturers of Ecopipam Hydrochloride
Table 8. Major Manufacturers of Others
Table 9. Global Tourette Syndrome Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Tourette Syndrome Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Tourette Syndrome Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Tourette Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Tourette Syndrome Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Tourette Syndrome Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Tourette Syndrome Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Tourette Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tourette Syndrome Drug as of 2019)
Table 18. Tourette Syndrome Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Tourette Syndrome Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Tourette Syndrome Drug Price (2015-2020) (USD/Pcs)
Table 21. Tourette Syndrome Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Tourette Syndrome Drug Product Type
Table 23. Date of International Manufacturers Enter into Tourette Syndrome Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Tourette Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Tourette Syndrome Drug Sales Share by Type (2015-2020)
Table 27. Global Tourette Syndrome Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Tourette Syndrome Drug Revenue Share by Type (2015-2020)
Table 29. Tourette Syndrome Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Tourette Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Tourette Syndrome Drug Sales Share by Application (2015-2020)
Table 32. North America Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 34. North America Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Tourette Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
Table 38. North America Tourette Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Tourette Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Tourette Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Tourette Syndrome Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Tourette Syndrome Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Tourette Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Tourette Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Tourette Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Tourette Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Tourette Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Tourette Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
Table 72. Abide Therapeutics Inc Corporation Information
Table 73. Abide Therapeutics Inc Description and Major Businesses
Table 74. Abide Therapeutics Inc Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Abide Therapeutics Inc Product
Table 76. Abide Therapeutics Inc Recent Development
Table 77. Catalyst Pharmaceuticals Inc Corporation Information
Table 78. Catalyst Pharmaceuticals Inc Description and Major Businesses
Table 79. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Catalyst Pharmaceuticals Inc Product
Table 81. Catalyst Pharmaceuticals Inc Recent Development
Table 82. Neurocrine Biosciences Inc Corporation Information
Table 83. Neurocrine Biosciences Inc Description and Major Businesses
Table 84. Neurocrine Biosciences Inc Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Neurocrine Biosciences Inc Product
Table 86. Neurocrine Biosciences Inc Recent Development
Table 87. Psyadon Pharmaceuticals Inc Corporation Information
Table 88. Psyadon Pharmaceuticals Inc Description and Major Businesses
Table 89. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Psyadon Pharmaceuticals Inc Product
Table 91. Psyadon Pharmaceuticals Inc Recent Development
Table 92. Reviva Pharmaceuticals Inc Corporation Information
Table 93. Reviva Pharmaceuticals Inc Description and Major Businesses
Table 94. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Reviva Pharmaceuticals Inc Product
Table 96. Reviva Pharmaceuticals Inc Recent Development
Table 97. Synchroneuron Inc Corporation Information
Table 98. Synchroneuron Inc Description and Major Businesses
Table 99. Synchroneuron Inc Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Synchroneuron Inc Product
Table 101. Synchroneuron Inc Recent Development
Table 102. Teva Pharmaceutical Industries Ltd Corporation Information
Table 103. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 104. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Teva Pharmaceutical Industries Ltd Product
Table 106. Teva Pharmaceutical Industries Ltd Recent Development
Table 107. Therapix Biosciences Ltd Corporation Information
Table 108. Therapix Biosciences Ltd Description and Major Businesses
Table 109. Therapix Biosciences Ltd Tourette Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Therapix Biosciences Ltd Product
Table 111. Therapix Biosciences Ltd Recent Development
Table 112. Global Tourette Syndrome Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global Tourette Syndrome Drug Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global Tourette Syndrome Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global Tourette Syndrome Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: Tourette Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: Tourette Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: Tourette Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: Tourette Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: Tourette Syndrome Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: Tourette Syndrome Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: Tourette Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: Tourette Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: Tourette Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: Tourette Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Tourette Syndrome Drug Players
Table 130. Tourette Syndrome Drug Customers List
Table 131. Tourette Syndrome Drug Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Tourette Syndrome Drug Product Picture
Figure 2. Global Tourette Syndrome Drug Sales Market Share by Type in 2020 & 2026
Figure 3. AZD-5213 Product Picture
Figure 4. CPP-115 Product Picture
Figure 5. Dutetrabenazine ER Product Picture
Figure 6. Ecopipam Hydrochloride Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tourette Syndrome Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Research Center
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Tourette Syndrome Drug Report Years Considered
Figure 14. Global Tourette Syndrome Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Tourette Syndrome Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Tourette Syndrome Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Tourette Syndrome Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Tourette Syndrome Drug Sales Market Share by Region in 2019
Figure 19. Global Tourette Syndrome Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Tourette Syndrome Drug Revenue Market Share by Region in 2019
Figure 21. Global Tourette Syndrome Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Tourette Syndrome Drug Revenue in 2019
Figure 23. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Tourette Syndrome Drug Sales Market Share by Type in 2019
Figure 26. Global Tourette Syndrome Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Tourette Syndrome Drug Revenue Market Share by Type in 2019
Figure 28. Global Tourette Syndrome Drug Market Share by Price Range (2015-2020)
Figure 29. Global Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Tourette Syndrome Drug Sales Market Share by Application in 2019
Figure 31. Global Tourette Syndrome Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Tourette Syndrome Drug Revenue Market Share by Application in 2019
Figure 33. North America Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 36. North America Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Tourette Syndrome Drug Market Share by Type in 2019
Figure 42. North America Tourette Syndrome Drug Market Share by Application in 2019
Figure 43. Europe Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 46. Europe Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 47. Germany Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Tourette Syndrome Drug Market Share by Type in 2019
Figure 58. Europe Tourette Syndrome Drug Market Share by Application in 2019
Figure 59. Asia Pacific Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region in 2019
Figure 63. China Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Tourette Syndrome Drug Market Share by Type in 2019
Figure 86. Asia Pacific Tourette Syndrome Drug Market Share by Application in 2019
Figure 87. Latin America Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 90. Latin America Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Tourette Syndrome Drug Market Share by Type in 2019
Figure 98. Latin America Tourette Syndrome Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Tourette Syndrome Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Tourette Syndrome Drug Market Share by Application in 2019
Figure 111. North America Tourette Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Tourette Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Tourette Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Tourette Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Tourette Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Tourette Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Tourette Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Tourette Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Tourette Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Tourette Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
レノックス・ガストー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lennox-Gastaut Syndrome Drug Market The global Lennox-Gastaut Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lennox-Gastaut Syndrome Drug Scope and Market Size Lennox…- 好酸球増加症候群薬の世界市場（～2026年） Market Analysis and Insights: Global Hypereosinophilic Syndrome Drug Market The global Hypereosinophilic Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hypereosinophilic Syndrome Drug Scope and Market Si…
- 基底細胞母斑症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Basal Cell Nevus Syndrome Drug Market The global Basal Cell Nevus Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Basal Cell Nevus Syndrome Drug Scope and Market Size …
- 非定型溶血性尿毒症症候群薬の世界市場（～2026年） Market Analysis and Insights: Global Atypical Hemolytic Uremic Syndrome Drug Market The global Atypical Hemolytic Uremic Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Atypical Hemolytic Uremic Syndrome …
- 癌性食欲不振-悪液質症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Cancer Anorexia-Cachexia Syndrome Drug Market The global Cancer Anorexia-Cachexia Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Anorexia-Cachexia Syndrome Dru…